V
Valentina Fava
Researcher at University of Catania
Publications - 23
Citations - 384
Valentina Fava is an academic researcher from University of Catania. The author has contributed to research in topics: Sexual function & Pelvic pain. The author has an hindex of 8, co-authored 23 publications receiving 290 citations.
Papers
More filters
Journal ArticleDOI
Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
TL;DR: Women on DNG/EE COC continuous regimen reported a reduction of endometriosis-associated pelvic pain and there was an improvement of their sexual activity and their QoL that was better than the D NG/EE 21/7 conventional regimen.
Journal ArticleDOI
Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy
Salvatore Caruso,Stefano Cianci,Salvatore Giovanni Vitale,Valentina Fava,Silvia Cutello,Antonio Cianci +5 more
TL;DR: Women who underwent termination of pregnancy experienced positive changes in QoL and sexual function during LNG-IUS use, however, not all women could adopt the LNG -IUS because of the cost of the contraceptive.
Journal ArticleDOI
Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.
TL;DR: The progressive reduction of the pain syndrome reported by women over the treatment period could contribute to improve the QoL and sexual life of women on DNG.
Journal ArticleDOI
Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain
Salvatore Caruso,Marco Iraci,Stefano Cianci,Salvatore Giovanni Vitale,Valentina Fava,Antonio Cianci +5 more
TL;DR: Long-term treatment with DNG 2 mg once-daily in women with endometriosis-associated pelvic pain may have positive effects on the QoL and sexual life, confirming the observations of the previous study on the first 6 months of treatment.
Journal ArticleDOI
Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17β-Estradiol.
Salvatore Caruso,Stefano Cianci,Maria Cariola,Valentina Fava,Salvatore Di Pasqua,Antonio Cianci +5 more
TL;DR: The effects of a combined oral contraceptive (COC) containing 17β-estradiol (E2) and nomegestrol acetate and NOMAC/E2 on the sexual health of women affected by low sexual desire due to COCs containing ethinylestradio were investigated.